Related Experiment Videos
[Platelet activating factor and pulmonary tuberculosis]
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|January 1, 1995
Summary
Platelet-activating factor (PAF) levels are significantly elevated in patients with active pulmonary tuberculosis, particularly in plasma and neutrophils. These findings suggest PAF
Area of Science:
- Immunology
- Infectious Diseases
- Biochemistry
Background:
- Pulmonary tuberculosis is a significant global health challenge.
- Platelet-activating factor (PAF) is a potent inflammatory mediator.
- Understanding PAF's role in tuberculosis pathogenesis is crucial.
Purpose of the Study:
- To quantify platelet-activating factor (PAF) levels in patients with active pulmonary tuberculosis.
- To investigate PAF content in plasma, blood, and neutrophils.
- To assess PAF changes after neutrophil stimulation.
Main Methods:
- Measured PAF in plasma, blood, and neutrophils of 74 tuberculosis patients and 12 healthy controls.
- Utilized the rabbit platelet aggregation technique for PAF quantification.
- Incubated neutrophils with killed BCG culture to assess stimulated PAF release.
Main Results:
- Elevated plasma PAF levels were observed in approximately half of the patients.
- Highest PAF concentrations correlated with newly diagnosed disease, cavity formation, high sputum bacilli load, and lymphopenia.
- Native neutrophils from patients contained 10 times more PAF than controls.
- Stimulated neutrophils from patients released 3 times more PAF into the incubation medium compared to controls.
Conclusions:
- Active pulmonary tuberculosis is associated with significantly higher PAF levels in plasma and neutrophils.
- PAF may play a critical role in the inflammatory response and disease progression in tuberculosis.
- Further research into PAF's therapeutic potential in tuberculosis is warranted.